Overexpressed genes/ESTs and characterization of distinct amplicons on 17q23 in breast cancer cells

• Published in: Neoplasia (New York, N.Y.) Vol. 3; no. 6; pp. 521 - 526
• Main Authors: Erson, A E, Niell, B L, DeMers, S K, Rouillard, J M, Hanash, S M, Petty, E M
• Format: Journal Article
• Language: English
• Published: United States 01-11-2001
• Subjects: Blotting, Northern; Blotting, Southern; Breast Neoplasms - genetics; Breast Neoplasms - pathology; Cell Line, Transformed; Cell Transformation, Viral; chromosome 17; Chromosomes, Human, Pair 17 - genetics; Contig Mapping; DNA, Neoplasm - genetics; Expressed Sequence Tags; Female; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; MUL gene; Neoplasm Proteins - biosynthesis; Neoplasm Proteins - genetics; Oncogenes; Papillomaviridae - physiology; Polymerase Chain Reaction - methods; PSK gene; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - genetics; RNA, Neoplasm - genetics; RPS6KB1 gene; TBX2 gene; Tumor Cells, Cultured
• ISSN: 1522-8002
• DOI: 10.1038/sj.neo.7900187

17q23 is a frequent site of gene amplification in breast cancer. Several lines of evidence suggest the presence of multiple amplicons on 17q23. To characterize distinct amplicons on 17q23 and localize putative oncogenes, we screened genes and expressed sequence tags (ESTs) in existing physical and radiation hybrid maps for amplification and overexpression in breast cancer cell lines by semiquantitative duplex PCR, semiquantitative duplex RT-PCR, Southern blot, and Northern blot analyses. We identified two distinct amplicons on 17q23, one including TBX2 and another proximal region including RPS6KB1 (PS6K) and MUL. In addition to these previously reported overexpressed genes, we also identified amplification and overexpression of additional uncharacterized genes and ESTs, some of which suggest potential oncogenic activity. In conclusion, we have further defined two distinct regions of gene amplification and overexpression on 17q23 with identification of new potential oncogene candidates. Based on the amplification and overexpression patterns of known and as of yet unrecognized genes on 17q23, it is likely that some of these genes mapping to the discrete amplicons function as oncogenes and contribute to tumor progression in breast cancer cells.